Clinical Impact of New Data From Virtual ECCVID 2020

Virtual Conference
In this downloadable slideset, CCO’s expert faculty summarizes important studies from this timely conference, including new data that illuminate key aspects of the transmission, pathogenesis, treatment, and prevention of COVID-19.
Barbara Rath, MD, PhD, HDR
Format: Microsoft PowerPoint (.ppt)
File Size: 1,010 KB
Released: October 9, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by:
Merck Sharp & Dohme Corp.

Related Content

Professor Leo Yee-Sin discusses data on the incidence of community- and hospital-acquired secondary infections in patients with COVID-19, from CCO

Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: October 22, 2020

Dr. Jens Lundgren discusses recently published and unpublished data on the use of immunomodulatory agents to treat COVID-19 from CCO

Jens D. Lundgren, MD, DMSc Released: October 16, 2020

Barbara Rath, MD, PhD, HDR, discusses emerging COVID-19 data reported at the Virtual ECCVID 2020 Conference, in the CCO Infectious Disease podcast

Released: October 16, 2020

This presentation by Dr. Vikram Mukherjee discusses key expert recommendations for the management of comorbid conditions in patients with COVID-19.

Vikramjit Mukherjee, MD Released: October 9, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue